Disease-modifying therapies for MS that prevent brain volume loss are linked to reduced long-term disability, new data show.

In another first, Sandoz launched in November 2025 the first FDA-approved biosimilar of Tysabri (natalizumab). Tyruko (natalizumab-sztn) is used to treat adult patients with relapsing multiple ...

Grey’s Anatomy Season 22 is expanding its cast with The Sopranos alum Jamie-Lynn Sigler. According to a new report, the ...

Grey’s Anatomy Season 22 is expanding its cast with The Sopranos alum Jamie-Lynn Sigler. According to a new report, the ...

An actress from "The Sopranos" will be returning to acting after a three-year break to guest-star in "Grey's Anatomy" as a ...

In 1989, one month after she got engaged, Koreen Burrow learned she has multiple sclerosis. Over the past 36 years, the ...

Researchers at Oregon Health & Science University have identified a type of enzyme with a complicated name - cell migration ...

Researchers at Oregon Health & Science University have identified a type of enzyme with a complicated name. Cell migration ...

The faster patients can be diagnosed with multiple sclerosis, the sooner they can begin taking the powerful medications that ...

Heisman Trophy finalist and Miami native Fernando Mendoza calls his mother his biggest inspiration. Elsa Mendoza is living ...

Researchers at Oregon Health & Science University have identified a type of enzyme with a complicated name — cell migration ...